Selecting criteria for monitoring patients with rheumatoid arthritis

被引:9
作者
Soubrier, M
Dougados, M
机构
[1] G Montpied Teaching Hosp, Dept Rheumatol, Serv Rhumatol, F-63003 Clermont Ferrand, France
[2] Univ Paris 05, AP HP Cochin Teaching Hosp, Dept Rheumatol B, F-75679 Paris, France
关键词
rheumatoid arthritis; disease activity; radiography; functional impairment;
D O I
10.1016/j.jbspin.2004.05.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Four treatment objectives govern the management of rheumatoid arthritis (RA): to control the clinical manifestations, to prevent structural damage. to prevent functional impairments, and to reduce excess mortality. Disease activity determines the extent of structural damage, the severity of functional impairments, and in part the excess mortality related to cardiovascular disease. In established RA, the functional impairments depend also on the extent of the structural damage. Methods for assessing disease activity, treatment responses, structural damage, and functional impairments are reviewed herein. A standardized follow-up protocol is suggested as a means of achieving greater uniformity in clinical practice. (c) 2004 Elsevier SAS. All rights reserved.
引用
收藏
页码:129 / 134
页数:6
相关论文
共 49 条
  • [1] Balsa A, 2004, J RHEUMATOL, V31, P40
  • [2] Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis
    Boers, M
    Nurmohamed, MT
    Doelman, CJA
    Lard, LR
    Verhoeven, AC
    Voskuyl, AE
    Huizinga, TWJ
    van de Stadt, RJ
    Dijkmans, BAC
    van der Linden, S
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (09) : 842 - 845
  • [3] Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by clinical experts and comparison with the smallest detectable difference
    Bruynesteyn, K
    van der Heijde, D
    Boers, M
    Saudan, A
    Peloso, P
    Paulus, H
    Houben, H
    Griffiths, B
    Edmonds, J
    Bresnihan, B
    Boonen, A
    van der Linden, S
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (04): : 913 - 920
  • [4] HYPERHOMOCYSTEINEMIA - AN INDEPENDENT RISK FACTOR FOR VASCULAR-DISEASE
    CLARKE, R
    DALY, L
    ROBINSON, K
    NAUGHTEN, E
    CAHALANE, S
    FOWLER, B
    GRAHAM, I
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) : 1149 - 1155
  • [5] Drossaers-Bakker KW, 1999, ARTHRITIS RHEUM, V42, P1854, DOI 10.1002/1529-0131(199909)42:9<1854::AID-ANR9>3.0.CO
  • [6] 2-F
  • [7] THE AMERICAN-COLLEGE-OF-RHEUMATOLOGY PRELIMINARY CORE SET OF DISEASE-ACTIVITY MEASURES FOR RHEUMATOID-ARTHRITIS CLINICAL-TRIALS
    FELSON, DT
    ANDERSON, JJ
    BOERS, M
    BOMBARDIER, C
    CHERNOFF, M
    FRIED, B
    FURST, D
    GOLDSMITH, C
    KIESZAK, S
    LIGHTFOOT, R
    PAULUS, H
    TUGWELL, P
    WEINBLATT, M
    WIDMARK, R
    WILLIAMS, HJ
    WOLFE, F
    [J]. ARTHRITIS AND RHEUMATISM, 1993, 36 (06): : 729 - 740
  • [8] AMERICAN-COLLEGE-OF-RHEUMATOLOGY PRELIMINARY DEFINITION OF IMPROVEMENT IN RHEUMATOID-ARTHRITIS
    FELSON, DT
    ANDERSON, JJ
    BOERS, M
    BOMBARDIER, C
    FURST, D
    GOLDSMITH, C
    KATZ, LM
    LIGHTFOOT, R
    PAULUS, H
    STRAND, V
    TUGWELL, P
    WEINBLATT, M
    WILLIAMS, HJ
    WOLFE, F
    KIESZAK, S
    [J]. ARTHRITIS AND RHEUMATISM, 1995, 38 (06): : 727 - 735
  • [9] Fransen J, 2003, ANN RHEUM DIS, V62, P151
  • [10] Mortality in early inflammatory polyarthritis - Cardiovascular mortality is increased in seropositive patients
    Goodson, NJ
    Wiles, NJ
    Lunt, M
    Barrett, EM
    Silman, AJ
    Symmons, DPM
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (08): : 2010 - 2019